Journal publications

Export 66 results:
Author Title Type [ Year(Asc)]
Filters: Type is Journal Article  [Clear All Filters]
El-Bouzidi K, White E, Mbisa JL, Sabin CA, Phillips AN, Mackie NE, Pozniak A, Tostevin A, Pillay D, Dunn D et al..  2016.  HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. J Antimicrob Chemother. 71(12)
Ragonnet-Cronin M, Shilaih M, Gunthard H.F, Hodcroft EB, Boni J, Fearnhill E, Dunn D, Yerly S, Klimait T, Aubert V et al..  2016.  A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland. Sci Rep. 6
Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, Asboe D, Pozniak A, Churchill D, Geretti AM et al..  2016.  Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom. HIV Med.
Ragonnet-Cronin M, Lycett SJ, Hodcroft EB, Hué S, Fearnhill E, Brown A.E, Delpech V, Dunn D, Leigh Brown A.J.  2016.  Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters. J Infect Dis. 213:1410-8.
De Luca A., Flandre P., Dunn D, Zazzi M, Wensing A., Santoro MM, Gunthard H.F, Wittkop L., Kordossis T., Garcia F. et al..  2016.  Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J Antimicrob Chemother. 71:1352-60.
Jose S., Quinn K., Dunn D, Cox A., Sabin C, Fidler S.  2016.  Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation. HIV Med. 17:368-72.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D, Dunn D, UK HIV Drug Resistance Database et al..  2016.  No evidence that HIV-1 subtype C infection compromises the efficacy of Tenofovir-containing: Cohort study in the United Kingdom. J Infect Dis.
Antiretroviral Therapy Cohort Collaboration(ART-CC), Canadian Observational Cohort Collaboration(CANOC), UK Collaborative HIV Cohort Study(UK CHIC), Collaboration of Observational HIV Epidemiological Research in Europe(COHERE).  2016.  Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. AIDS. 30(3)
TenoRes Study Group.  2016.  Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis.
Mbisa JL, Fearnhill E, Dunn D, Pillay D, Asboe D, Cane P A.  2015.  Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom. Clin Infect Dis. 61:829-36.
Mourad R, Chevennet F, Dunn D, Fearnhill E, Delpech V, Asboe D, Gascuel O, Hué S.  2015.  A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK. AIDS. 29:1917-25.
Takebe Y., Naito Y., Raghwani J., Fearnhill E, Sano T., Kusagawa S., Mbisa JL, Zhang H, Matano T., Leigh Brown A.J et al..  2014.  Intercontinental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan. J Virol. 88:9864-76.
Hué S, Brown A.E, Ragonnet-Cronin M, Lycett SJ, Dunn D, Fearnhill E, Dolling D, Pozniak A, Pillay D, Delpech V et al..  2014.  Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions. AIDS. 28:1967-75.
Hodcroft EB, Hadfield J, Fearnhill E, Phillips A, Dunn D, O’Shea S, Pillay D, Leigh Brown A.J.  2014.  The contribution of viral genotype to plasma viral set-point in HIV infection. PLoS Pathog. 10:e1004112.
UK HIV Drug Resistance Database.  2014.  The increasing genetic diversity of HIV-1 in the UK, 2002-2010. AIDS. 28:773-80.
Foster GM, Ambrose JC, Hué S, Delpech V, Fearnhill E, Abecasis AB, Leigh Brown A.J, Geretti A M.  2014.  Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D. PLoS One. 9:e83337.
Bulteel N, Bansi-Matharu L., Churchill D, Dunn D, Bibby D., Hill T, Sabin C, Nelson M.  2014.  The emergence of drug resistant HIV variants at virological failure of HAART combinations containing efavirenz, tenofovir and lamivudine or emtricitabine within the UK Collaborative HIV Cohort. J Infect. 68:77-84.
Ragonnet-Cronin M, Hodcroft EB, Hué S, Fearnhill E, Delpech V, Leigh Brown A.J, Lycett SJ.  2013.  Automated analysis of phylogenetic clusters. BMC Bioinformatics. 14:317.
Castro H, Pillay D, Cane P A, Asboe D, Cambiano V, Phillips A, Dunn D.  2013.  Persistence of HIV-1 transmitted drug resistance mutations. J Infect Dis. 208:1459-63.
Dolling D, Dunn D, Sutherland K.A, Pillay D, Mbisa JL, Parry C.M, Post FA, Sabin C, Cane P A.  2013.  Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study. J Antimicrob Chemother. 68:2339-43.